HHC
DGX icon

Hutchin Hill Capital’s Quest Diagnostics DGX Stock Holding History

Hutchin Hill Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,000
Closed -$2.25M – 469
2017
Q3 		$2.25M Buy
24,000
+13,600
+131% +$1.44M 0.08% 209
2017
Q2 		$1.16M Buy
10,400
+4,400
+73% +$465K 0.04% 468
2017
Q1 		$589K Buy
+6,000
New +$572K 0.02% 594

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hutchin Hill Capital's DGX Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 24,000 shares — an estimated $2.25M sold.

Hutchin Hill Capital first reported a position in DGX in Q1 2017 and held it in 3 quarters. The position peaked at $2.25M in Q3 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 24,000 Quest Diagnostics shares in Q4 2017, an estimated $2.25M.
  • Hutchin Hill Capital first reported a position in Quest Diagnostics in Q1 2017 and held it in 3 quarters.
  • Hutchin Hill Capital's Quest Diagnostics position peaked at $2.25M in Q3 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.